Hypertension

(100) Artificial intelligence (machine learning) and molecular classification of sibling twin (TW) placentas in preeclampsia (PE).

(131) Urinary Immune Complexome Profiling Allows for Clinical Subphenotype Differentiation in Preeclampsia (PE)

(145) Acute treatment of severe hypertension in pregnancies with fetal growth restriction: Does medication choice matter?

(160) Blood pressure levels in pregnancy and adverse maternal metabolic health 10-14 years postpartum

(182) Advanced maternal age among primigravida as a risk factor for long-term cardiovascular disease

(183) Is preeclampsia with low sodium levels associated with preterm birth?

(184) Risk factors for postpartum refractory hypertension and consequent pregnancy outcomes

(253) Aspirin dose effect on uterine artery Doppler in patients stratified by biomarkers: ASPERIN secondary analysis

(256) Activity restriction and time from diagnosis to delivery among patients with preterm pre-eclampsia

(262) Antenatal Corticosteroid Exposure in those with Hypertensive Disorders of Pregnancy: A Population Cohort Study

(263) The utility of PlGF as a “rule-out” test: examining outcomes after triage testing

(288) Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: A Noninferiority Randomized Controlled Trial

(297) 12 Versus 24 Hours of Postpartum Magnesium Sulfate for Seizure Prophylaxis: A Cost-Effective Analysis

(299) Acute post-neuraxial hypotension in patients with hypertensive disorder is associated with fetal acidemia

(309) Aspirin Decreases Triglycerides in the Development of Preeclampsia

(310) Risk of Hypertension Progression after Pregnancies Complicated by American Heart Association (AHA) Stage 1 Hypertension

(311) Biomarkers of Poor Volume Handling Predict Preeclampsia in a Symptomatic Population

(328) Activin A as a marker of postpartum hypertension following a hypertensive disorder of pregnancy.

(343) Timing of delivery in women with pre-existing hypertension and stillbirth risk: A retrospective population-based study

(349) Antenatal aspirin prescription following the United States Preventive Services Task Force’s (USPSTF) 2021 practice update

(352) Remote blood pressure monitoring during pregnancy: Comparing patient engagement between connected and unconnected device users

(355) Body composition vs. traditional weight and BMI for assessing hypertensive disorders of pregnancy (HDOP) risk

(388) Eye towards Artificial Intelligence: Retinal Vascular Tortuosity vs. Vasoconstriction to Differentiate Preeclamptic and Normotensive Subjects

(398) Does Timing of Diagnosis of Hypertensive Disorders of Pregnancy Impact perinatal Outcomes?

(405) Expectant management of Early Onset Preeclampsia with Severe Features Before 24 weeks

(408) Blood pressure control in patients with pregestational diabetes and perinatal outcomes

(451) Urinary calcium to creatinine ratio for the prediction of preeclampsia: a systematic review and meta-analysis

(481) Engaging community doulas with a remote postpartum hypertension program for Black persons: A qualitative study

(484) Donor gamete status and hypertensive disorders of pregnancy in pregnancies conceived with assisted reproductive technologies

(528) Association of antenatal anxiety, short sleep duration, and blood pressure parameters: a pilot study

(529) Association between method of conception of DCDA twin pregnancies and hypertensive disorders of pregnancy

(541) Blood Pressure Threshold to Prevent Post Partum Readmission

(552) Effect of Oral Furosemide Use on Postpartum Readmissions and Blood Pressure Trends

(587) Does sFlt1/PIGF predict superimposed preeclampsia in women with chronic hypertension during pregnancy? A meta-analysis

(595) Examining the Relationship between Maternal Preeclampsia and Autism Spectrum Disorder in Childhood: A Cohort Analysis

(597) De novo hypertension in the late postpartum period: a case for extending postpartum care

(601) Evolution of hypertension stages in pregnancy and postpartum from 2013-2022

(615) Expectant management of preeclampsia with severe features: clinical outcomes based on severe features at diagnosis

(635) Effect of Medications on Postpartum Cerebral Autoregulation in Preeclampsia with Severe Features

(638) Assessment of Maternal and Neonatal Outcomes in Newly Diagnosed Intrapartum Gestational Hypertension

(639) Eclampsia and adverse effects: comparison between 1 versus 2 grams per hour intravenous magnesium sulfate

(674) Mean arterial pressure as an early predictor of preeclampsia: A retrospective cohort study

(675) Understanding Fluid Shifts in Hypertension: Postpartum Point-of-Care Ultrasound of the Inferior Vena Cava and Aorta

(676) White coat hypertension validated on home blood pressure monitoring as predictor of adverse pregnancy outcomes

(689) Maternal morbidity in postpartum severe preeclampsia by obstetric hospital volume

(813) Trends in Hypertensive Disorders in the United States Post Aspirin Recommendation Guidelines: A Nationwide Study

(837) NT-ProBNP in preeclampsia with severe features as a predictor of adverse maternal cardiac outcomes

(870) MicroRNAs as Markers of Aspirin Response and Pregnancy Outcome in High Risk Singletons

(924) Serum magnesium levels: does maternal weight matter?

(948) Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy

(951) Preeclampsia in patients with adult congenital heart disease

(962) Social determinants of health impact the development of new-onset postpartum hypertension

(992) Plasma sFlt-1/PlGF ratio as MoM improves prediction of preeclampsia with severe features within two weeks

(993) Plasma sFlt-1/PlGF ratio in MoM and Severe Adverse Neonatal Outcomes in Non-preeclamptic Patients

(1010) The relationship between platelets indices and hypertensive disorders of pregnancy

(1029) Postpartum preeclampsia readmissions- Is de novo postpartum hypertension worse?

(1043) Magnesium sulfate administration in preeclampsia without severe features and perinatal outcomes

(1059) Maternal Angiogenic Imbalance & Placental Sexual Dimorphism

(1067) Preeclampsia associated genetic variants near FLT1 are associated with elevated late pregnancy maternal serum sFLT1

(1072) The association between maternal preeclampsia and long-term offspring respiratory disease- sibling matched analysis

(1082) Resolution of postpartum hypertension among Asian, Black, and Hispanic patients with hypertensive disorders of pregnancy

(1095) The Role of Long-Acting Antihypertensives in Preeclampsia with Severe Features

(1112) Prevalence rates of chronic hypertension and hypertensive disorders of pregnancy: US national trends 2015-2020

(1118) Postpartum Antihypertensive Choice and Readmission Outcomes

(1138) Prediction of Pregnancy Outcomes by Various Blood Pressure Metrics among Patients with Mild Chronic Hypertension

(1144) Predicting preeclampsia and gestational hypertension using the vasculature of the eye

(1153) Progression in AHA stage of hypertension and cardiovascular disease risk among ACOG-defined normotensive individuals

(1156) Preeclamptic or History-of-COVID-19 CD4+ T Cells Contribute to Hypertension, Neurovascular Dysfunction Postpartum and in Offspring.

(1169) Postpartum Beat-to-Beat Systolic Blood Pressure Variability in Preeclampsia with Severe Features

(1192) The Evolving Landscape of Biomedical Informatics for Postpartum Hypertension: A Scoping Review